Impact of an evolving regulatory landscape on skin cancer drug development in the U.S.
Sign Up to like & getrecommendations! Published in 2022 at "Dermatology online journal"
DOI: 10.5070/d328257391
Abstract: BACKGROUND There has been a rapid proliferation of FDA-approved medications with labeled indications for skin cancer over the last decade, with particular growth over the last 5 years. OBJECTIVE We aimed to evaluate the impact… read more here.
Keywords: impact evolving; skin cancer; evolving regulatory; drug ... See more keywords